For ncRAN, deregulation has been reported in neuroblastoma [41], colorectal cancer [42] and in bladder cancer, where a limited number of cancer tissues were investigated by semi-quantitative PCR [10]. This evidence concerns the gene SNHG16 and urinary bladder carcinoma.